Dr. Vakkalagadda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3485 S Bond Ave
Building 2
Portland, OR 97239
Summary
- Chetan Vakkalagadda, MD, is a medical oncologist based in Portland, OR, with a focus on cancers of the thorax. He completed his fellowship in hematology and medical oncology and his residency in internal medicine at McGaw Medical Center of Northwestern University, following his MD from Washington University in St. Louis School of Medicine. Dr. Vakkalagadda currently serves as an Assistant Professor of Medicine at the OHSU Knight Cancer Institute. He has published research on topics such as next-generation sequencing in lung cancer and novel therapies in relapsed/refractory Hodgkin lymphoma.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2020 - 2023
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2017 - 2020
- Washington University in St. Louis School of MedicineClass of 2017, MD
- Washington University in St. LouisBA, Chemistry (Biochemistry), Cum Laude, 2009 - 2013
Certifications & Licensure
- WA State Medical License 2023 - 2026
- OR State Medical License 2023 - 2025
- IL State Medical License 2017 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The Impact of Next-Generation Sequencing Workflows on Outcomes in Advanced Lung Cancer: A Retrospective Analysis at One Academic Health System.Chetan V Vakkalagadda, Danielle B Dressler, Zequn Sun, Joseph Fuchs, Yingzhe Liu
Cancers. 2024-10-30 - 1 citationsAddition of Trastuzumab Deruxtecan to Selpercatinib in a Patient With RET Fusion-Driven NSCLC and an Acquired HER2 Amplification: Case Report.Chetan V Vakkalagadda, Jyoti D Patel
JTO Clinical and Research Reports. 2023-12-01 - 10 citationsNovel Therapies and Approaches to Relapsed/Refractory HL Beyond ChemotherapyAlain Mina, Chetan Vakkalagadda, Barbara Pro
Cancers. 2019-03-25
Books/Book Chapters
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: